NanoSphere Health Sciences Logo
CA63010P2098
A3CRGY
NSHSF

NanoSphere Health Sciences

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2024, NanoSphere Health Sciences has already paid €0.38 in dividends. The last payout was in June 2024.

Financials

In the last quarter, NanoSphere Health Sciences had revenue of €0 and net profit of -€41.36k
(EUR) June 2026
YoY
Revenue 0 -
Gross profit 0 -
Net profit -41.36k 209.49%
EBITDA 0 100.00%

Fundamentals

Metric Value
Market capitalization
€62.27k
Number of shares
10.28m
52-week high/low
€0.0119 - €0.00371
Dividends No
Beta
0.64
P/E ratio
9.40
PEG ratio
-0.07
P/B ratio
-0.11
P/S ratio
0.00

Company profile

NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Deliver System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The company was incorporated in 2005 and is headquartered in Vancouver, Canada.

Name
NanoSphere Health Sciences
CEO
Michael Alexander Iverson
Headquarters Vancouver, bc
Canada
Website
IPO
08/10/2009
Employees 3

Ticker symbols

Exchange Symbol
Pnk
NSHSF
Frankfurt
2CG.F
Cnq
NSHS.CN
Sto
ANNE-B.ST
Nse
ICIL.NS
Shh
605003.SS
Tlv
ALTF.TA
🍪

Parqet  uses cookies. Learn more